http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1338294-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_204ea9f0f83d1c51a916e46a41a6a14a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-46
filingDate 1971-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1973-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1338294-A
titleOfInvention 2-3-2-tetrahydrofuryl-propionyl-1,3-cyclopentanedione and production of this physiologically active compound
abstract 1338294 Tetrahydrofuryl - propionyl cyclopentanedione ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI 10 Aug 1971 [21 Aug 1970 1 Sept 1970] 37416/71 Heading C2C The novel compound of Formula (I) may be obtained by hydrogenation of 2[3-(2- furyl) - acryloyl] - 1,3 - cyclopentanedione in the presence of a base and of a hydrogenation catalyst comprising Pt, Pd or Rh, and optionally liberating the free form from its salt by treatment with dilute acid. The starting material may be obtained by aldol condensation of 2-acetyl-1,3-cyclopentanedione with furfural. In an example, 2-(4,5- dihydro - 5 - propyl - 2(3H) - furylidene) - 1,3- cyclopentanedione is obtained as a by-product. Pharmaceutical compositions having hypotensive activity comprise the compound of Formula (I) together with a pharmaceutical carrier in forms suitable for oral or parenteral administration.
priorityDate 1970-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154310075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415943495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID325277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID336473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68150012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432371656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427960411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415940417

Total number of triples: 26.